MMD

MMD is a multi-pass membrane protein that localizes to the Golgi apparatus (and also the endoplasmic reticulum and mitochondria) and functions as a scaffold linking lipid-remodeling enzymes and inflammatory signaling pathways (PMID:22203480, PMID:37691145). At the Golgi, MMD physically associates with ACSL4 and MBOAT7, promoting arachidonic acid incorporation into phosphatidylinositol species and thereby sensitizing cells to ferroptosis (PMID:37691145). In macrophages and microglia, MMD amplifies LPS-stimulated ERK1/2 and Akt phosphorylation, driving TNF-α and nitric oxide production; this signaling axis is post-transcriptionally repressed by miR-140-5p, which directly targets the MMD 3′UTR (PMID:22203480, PMID:24971538, PMID:36336031).

1. 2011 Medium

   Establishing where MMD resides and that it couples to inflammatory signaling resolved the basic question of how a differentiation-associated gene exerts cellular effects: MMD localizes to ER, mitochondria, and Golgi, and its overexpression in macrophages enhances LPS-triggered ERK1/2 and Akt phosphorylation to increase TNF-α and NO output.

   Evidence EGFP-MMD live-cell colocalization with organelle markers and overexpression with pharmacological ERK/Akt inhibitors in macrophage cell lines

   PMID:22203480

   Open questions at the time

   • Overexpression-only design; endogenous loss-of-function not tested
   • Mechanism by which MMD activates ERK/Akt is unknown (direct kinase scaffolding vs. indirect)
   • No interacting proteins identified at this stage
2. 2014 Medium

   Demonstrating that miR-140-5p directly targets MMD to restrain ERK-driven proliferation established both a post-transcriptional regulatory mechanism and a functional role for MMD in cancer cell growth.

   Evidence Luciferase reporter assay confirming miR-140-5p binding to MMD 3′UTR, siRNA knockdown reducing A549/LLC proliferation in vitro and xenograft growth in vivo

   PMID:24971538

   Open questions at the time

   • Single cancer type (lung); generalizability unconfirmed
   • Whether MMD promotes proliferation through ERK alone or additional pathways is unresolved
   • No mechanistic connection to MMD's membrane/scaffold function
3. 2022 Medium

   Extending miR-140-5p–MMD regulation to neuroinflammation showed that extracellular-vesicle-delivered miR-140-5p suppresses MMD in microglia, dampening both PI3K/AKT and ERK1/2 signaling and reducing inflammatory cytokine release after brain injury.

   Evidence Microglia-derived EV transfer of miR-140-5p, luciferase target validation, subarachnoid hemorrhage rat model with immunofluorescence for microglial polarization

   PMID:36336031

   Open questions at the time

   • Single in vivo model (SAH in rats); relevance to other neuroinflammatory contexts untested
   • Whether MMD's scaffold function at the Golgi is involved in microglia signaling is unknown
   • Endogenous stoichiometry of miR-140-5p–MMD regulation not quantified
4. 2023 High

   Identifying MMD as a Golgi-resident scaffold that bridges ACSL4 and MBOAT7 to channel arachidonic acid into phosphatidylinositol revealed the first direct molecular mechanism for MMD, explaining how it sensitizes cells to ferroptosis through lipid remodeling.

   Evidence Reciprocal co-immunoprecipitation of MMD with ACSL4 and MBOAT7, lipidomics profiling of AA-PI species, ferroptosis viability assays with genetic epistasis in ovarian and renal carcinoma cells

   PMID:37691145

   Open questions at the time

   • Structural basis of the MMD–ACSL4–MBOAT7 complex is unresolved
   • Whether the scaffolding role is relevant to MMD's ERK/Akt signaling function is unknown
   • In vivo physiological relevance of MMD-dependent ferroptosis sensitization not yet tested

• It remains unknown how MMD's lipid-remodeling scaffold function at the Golgi relates mechanistically to its amplification of ERK/Akt inflammatory signaling, and whether these represent independent or coupled activities.
• No structural model of MMD or its complexes exists
• Endogenous knockout phenotype in primary macrophages or in vivo immune models has not been reported
• Whether MMD's PAQR-family topology confers any receptor-like or channel-like activity is untested